Browse our anti-EGFR (EGFR) Antibodies

Full name:
anti-Epidermal Growth Factor Receptor Antibodies (EGFR)
On are 2279 Epidermal Growth Factor Receptor (EGFR) Antibodies from 44 different suppliers available. Additionally we are shipping EGFR Kits (141) and EGFR Proteins (113) and many more products for this protein. A total of 2606 EGFR products are currently listed.
9030024J15Rik, AI552599, C-erb, c-erbB, CG10079, D-Egf, d-egf-r, D-EGFR, dEgfr, dEGFR1, der, DER/EGFR, DER/faint little ball, DER/top, DER/torpedo, DER1, DER flb, Dmel\\CG10079, DmHD-33, EFG-R, Egf, Egf-r, egfr, egfr1, EGFR12, EGFR15, EK2-6, El, Elp, Elp-1, Elp-B1, Elp-B1RB1, Erbb, ErbB-1, ERBB1, Erbb2, Errb1, Errp, flb, HD-33, HER1, l(2)05351, l(2)09261, l(2)57DEFa, l(2)57Ea, l(2)57EFa, mENA, mor1, PIG61, top, top/DER, top/flb, Torpedo/DER, torpedo/egfr, wa-2, wa2, Wa5
list all antibodies Gene Name GeneID UniProt
EGFR 1956 P00533
EGFR 24329  
EGFR 13649 Q01279

Show all species

Show all synonyms

All available anti-EGFR Antibodies

Go to our pre-filtered search.

Top referenced anti-EGFR Antibodies

  1. Human Polyclonal EGFR Primary Antibody for EIA - ABIN358328 : Aifa, Aydin, Nordvall, Lundström, Svensson, Hermanson: A basic peptide within the juxtamembrane region is required for EGF receptor dimerization. in Experimental cell research 2004 (PubMed)
    Show all 5 references for 358328

  2. Human Polyclonal EGFR Primary Antibody for WB - ABIN391933 : Kuribayashi, Kataoka, Kurabayashi, Miura: Evidence that basal activity, but not transactivation, of the epidermal growth factor receptor tyrosine kinase is required for insulin-like growth factor I-induced activation of extracellular signal-regulated kinase in oral carcinoma cells. in Endocrinology 2004 (PubMed)
    Show all 3 references for 391933

  3. Human Polyclonal EGFR Primary Antibody for DB, WB - ABIN389891 : Kapoor, Zhan, Johnson, ORourke: Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor/NF-kappaB activation through Gab1 in glioblastoma cells. in Molecular and cellular biology 2003 (PubMed)
    Show all 3 references for 389891

  4. Human Polyclonal EGFR Primary Antibody for ELISA, WB - ABIN1532008 : Ullrich, Coussens, Hayflick, Dull, Gray, Tam, Lee, Yarden, Libermann, Schlessinger: Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. in Nature 1984 (PubMed)

  5. Human Polyclonal EGFR Primary Antibody for FACS, IHC (p) - ABIN651628 : Lowenstein, Daly, Batzer, Li, Margolis, Lammers, Ullrich, Skolnik, Bar-Sagi, Schlessinger: The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. in Cell 1992 (PubMed)

  6. Human Monoclonal EGFR Primary Antibody for FACS, IF - ABIN452102 : Wikstrand, Hale, Batra, Hill, Humphrey, Kurpad, McLendon, Moscatello, Pegram, Reist: Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. in Cancer research 1995 (PubMed)

  7. Dog (Canine) Monoclonal EGFR Primary Antibody for EIA, IF - ABIN126767 : Kondo, Higa-Nakamine, Maeda, Toku, Kakinohana, Sugahara, Kukita, Yamamoto: Stimulation of Cell Migration by Flagellin Through the p38 MAP Kinase Pathway in Cultured Intestinal Epithelial Cells. in Journal of cellular biochemistry 2015 (PubMed)

  8. Human Monoclonal EGFR Primary Antibody for IHC (p) - ABIN1687358 : Krager, Sarkar, Twait, Lill, Koland: A novel biotinylated lipid raft reporter for electron microscopic imaging of plasma membrane microdomains. in Journal of lipid research 2012 (PubMed)

More Antibodies against EGFR Interaction Partners

Horse (Equine) Epidermal Growth Factor Receptor (EGFR) interaction partners

  1. Results indicated that most periocular squamous cell carcinomas of horses expressed epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2 (show ERBB2 Antibodies)).

Fruit Fly (Drosophila melanogaster) Epidermal Growth Factor Receptor (EGFR) interaction partners

  1. These results reveal that ESCRT-0 (ESCRT-0 components stam (show STAM Antibodies) and hrs)mutants inhibit EGFR signaling by disrupting Rhomboid endosomal trafficking in the ligand-producing cells.

  2. we find that EGFR regulates the apical determinant Crb and the extracellular matrix regulator Serp, two factors previously known to control tube length. EGFR regulates the organisation of endosomes in which Crb and Serp proteins are loaded

  3. Here we uncover a cell non-autonomous requirement for the Epidermal growth factor receptor (Egfr) pathway in the lateral epidermis for sustained dpp (show TGFb Antibodies) expression in the LE. Specifically, we demonstrate that Egfr pathway activity in the lateral epidermis prevents expression of the gene scarface (scaf), encoding a secreted antagonist of JNK (show MAPK8 Antibodies) signaling

  4. Loss of Usp5 (show USP5 Antibodies) results in upregulation of Notch (show NOTCH1 Antibodies) signaling and downregulation of RTK signaling by EGF receptor (EGFR) and Sevenless (Sev), leading to impaired photoreceptor development.

  5. These data demonstrate a strong genetic link between dG9a and the EGFR signaling pathway.

  6. Avermectin directly interacts with EGFR and leads to the activation of the EGFR/AKT (show AKT1 Antibodies)/ERK (show MAPK1 Antibodies) pathway.

  7. The dorsoventral patterning and EGFR signaling genes play essential roles in correct identity determination and differentiation of lateral glia in the Drosophila nervous system.

  8. Data suggest that OSCP1 (organic solute carrier partner 1 (show OSCP1 Antibodies)) plays multiple roles during eye development in D. melanogaster; OSCP1 (show OSCP1 Antibodies) regulates developmental gene expression and epidermal growth factor receptor signaling pathway in imaginal discs of eye.

  9. The vector of cell movement is regulated by localised epidermal growth factor (EGF (show EGF Antibodies)) signalling from the distally placed tip cell lineage and the acquisition of planar polarity leads to asymmetric pulsatile Myosin II accumulation.

  10. Our findings provide in vivo evidence for the role of adult neurons in the maintenance of glia and a novel role for EGFR signaling in the autophagic flux.

Zebrafish Epidermal Growth Factor Receptor (EGFR) interaction partners

  1. Study demonstrated that IGF-I (show IGF1 Antibodies) can stimulate egfr expression in both follicles cell culture and intact follicles promoting oocyte maturation.

  2. These results indicate that maintenance of Pgrmc1 (show PGRMC1 Antibodies) signaling is required for Egfr expression on zebrafish oocyte cell membranes and for conserving the functions of Egfr in maintaining meiotic arrest through estrogen activation of Gper (show GPER Antibodies).

  3. EGFR signaling in vertebrate oocytes can prevent meiotic progression.

  4. the expression of EGFR was mainly restricted to the follicle cells with little expression in the oocytes

Human Epidermal Growth Factor Receptor (EGFR) interaction partners

  1. Data suggest that NDRG1 (show NDRG1 Antibodies) attenuates oncogenic signaling by inhibiting formation of EGFR/HER2 (show ERBB2 Antibodies) and HER2 (show ERBB2 Antibodies)/HER3 (show ERBB3 Antibodies) heterodimers and by down-regulating EGFR via a mechanism involving its degradation. (NDRG1 (show NDRG1 Antibodies) = N-myc downstream regulated gene 1 protein (show NDRG1 Antibodies); EGFR = epidermal growth factor receptor; HER = human epidermal growth factor receptor) [REVIEW]

  2. EGFR positivity was independently associated with a worse outcome in adenocarcinoma of the esophagogastric junction.

  3. Atomistic molecular dynamics simulations show that N-glycosylation of the EGFR extracellular domain plays critical roles in the binding of growth factors, monoclonal antibodies, and the dimeric partners to the monomeric EGFR extracellular domain.

  4. This analysis is the first to reveal the relationship between EGFR mutation status and the spatial distribution of brain metastases of lung cancer.

  5. GOLM1 (show GOLM1 Antibodies) selectively interacts with epidermal growth factor receptor (EGFR) and serves as a specific cargo adaptor to assist EGFR/RTK anchoring on the trans-Golgi network (TGN (show TG Antibodies)) and recycling back to the plasma membrane, leading to prolonged activation of the downstream kinases.

  6. EGFR mutation turned out to have no change after EGFR-TKI therapy.

  7. Simultaneous suppression of ErbB kinases and androgen signaling by Celecoxib represents a novel strategy to interrupt the vicious cycle of AR/ErbB cross-talk with the primary purpose of undermining their resilient signaling in prostate cancer progression.

  8. Study shows that sequential epidermal growth factor receptor (EGFR) amplification and EGFRvIII mutations might represent concerted evolutionary events that drive the aggressive nature of glioblastoma by promoting invasion and angiogenesis via distinct signaling pathways.

  9. The occurrence of EGFR mutations in lung adenocarcinomas gradually increases with age, being attributed mainly to the increment of the L858R frequency in non-smokers.

  10. in HER2 (show ERBB2 Antibodies)-overexpressing D492 cells, EGFR can behave as a tumor suppressor, by pushing the cells towards epithelial differentiation

Mouse (Murine) Epidermal Growth Factor Receptor (EGFR) interaction partners

  1. Although EGFR activation promotes wound healing, released exosomes may antagonize EGFR activation and wound healing.

  2. opposing signals generated by different ErbB dimer combinations function in the same cardiac cushion mesenchymal cells for proper cardiac valve formation.

  3. Combined targeting of TGF-beta (show TGFB1 Antibodies), EGFR and HER2 (show ERBB2 Antibodies) signaling suppresses lymphangiogenesis and metastasis in a pancreatic ductal adenocarcinoma model.

  4. The conjugation of benzylguanine-modified auristatin F to EGFR-specific 425(scFv)-SNAP and HER2 (show ERBB2 Antibodies)-specific alphaHER2(scFv)-SNAP resulted in two potent recombinant antibody-drug conjugates that specifically killed breast cancer cell lines by inducing apoptosis when applied at nanomolar concentrations.

  5. data demonstrate a key role of EGFR in the host response to severe acute respiratory syndrome coronavirus and how it may be implicated in lung disease induced by other highly pathogenic respiratory viruses

  6. these data indicate that SerpinB5 (show SERPINB5 Antibodies) expression and phosphorylation are developmentally regulated. In vitro analyses indicate that SerpinB5 (show SERPINB5 Antibodies) phosphorylation is regulated by EGFR ligands, but EGF (show EGF Antibodies) appears to be the only able to induce SerpinB5 (show SERPINB5 Antibodies) nuclear localization.

  7. genome-wide association study and network-based approach adds evidence for a role for Egfr in murine pulmonary hypertension.

  8. Our results support a role for the hepatocellular ERBB tyrosine kinases in fibrogenesis. Maximal impact to fibrogenesis occurred in the ERBB3 (show ERBB3 Antibodies) and EGFR-ERBB3 (show ERBB3 Antibodies) DKO models, suggesting that EGFR-ERBB3 (show ERBB3 Antibodies) heterodimeric signaling in damaged hepatocytes may play a more important role in liver fibrosis than EGFR-EGFR homodimeric signaling.

  9. Our results demonstrate that Respiratory syncytial virus F interacts with EGFR in a strain-specific manner, EGFR is a co-factor for infection, and EGFR plays a role in RSV-induced mucin (show SLC13A2 Antibodies) expression

  10. These data highlight the importance of EGFR signaling and its downstream signaling cascade in postnatal beta cell growth.

Pig (Porcine) Epidermal Growth Factor Receptor (EGFR) interaction partners

  1. this study shows that anemonin may ameliorate LPS (show IRF6 Antibodies)-induced intestinal injury and improve restoration by regulating the TGF-b1 and EGFR signaling pathways

  2. Syndecan-4 (show SDC4 Antibodies) mediates porcine respiratory and reproductive syndrome virus entry by interacting with EGFR.

  3. These results indicate that cAMP and oocyte-secreted factors cooperate to promote EGF receptor functionality in developing cumulus oocyte complexes, representing a key component of the acquisition of oocyte developmental competence.

  4. patients experiencing gefitinib dose reduction or short-term treatment interruption due to toxicities did not show inferior survival, compared to those receiving full dose of gefitinib in non-small cell lung cancer patients with EGFR mutation

  5. Report EGFR expression in the normal pancreas.

  6. Injury and activation of purinergic receptors and direct activation of EGFR via EGF (show EGF Antibodies) induce distinct downstream pathways.

  7. Data suggest that the mechanism of hypoxia-induced increased activation of EGFR kinase is mediated by nNOS (show NOS1 Antibodies)-derived nitric oxide.

  8. EGFR, VEGFR (show KDR Antibodies) and FGFR (show FGFR2 Antibodies) are expressed in porcine oviduct and endometrium during the time of implantation [review]

  9. the restricted presence of the functional full-size receptor to the epithelial layer indicates a specific role during early embryonic development, whereas truncated EGF-R forms may potentially regulate contractions and blood flow in the oviduct

  10. The phase-related expression of EGF (show EGF Antibodies) and EGFR in the endothelium of the uterine artery and its branches suggest the modulatory effect of EGF (show EGF Antibodies) and its receptor on the uterine artery and the region supplying these vessels.

Cow (Bovine) Epidermal Growth Factor Receptor (EGFR) interaction partners

  1. Stimulation of bovine oviduct epithelial cell EGFR with EGF (show EGF Antibodies) (human recombinant EGF (show EGF Antibodies)) alone or with EGF (show EGF Antibodies) in postovulatory/follicular phases (not luteal phase) up-regulates phosphorylation of MAPKs; heat blocks effects of EGF (show EGF Antibodies) on phosphorylation of MAPKs.

  2. Expression of the erbB/HER receptor family in the bovine uterus during the sexual cycle and the relation of this family to serum sex steroids.

  3. Regulation of the sperm EGFR by ouabain leads to initiation of the acrosome reaction.

  4. EGFR may simultaneously activate c-Src (show SRC Antibodies) and PI3K to amplify the oxytocin signaling to increase the output of PGF (show PGF Antibodies)(2 alpha) in endometrial epithelial cells.

  5. results indicate that arginase induction depends in part on epidermal growth factor (EGF (show EGF Antibodies)) receptor activity, and that EGFR inhibitors may attenuate vascular remodeling without affecting nitric oxide release

  6. Data suggest that epidermal growth factor (EGF (show EGF Antibodies)) and EGF (show EGF Antibodies) receptors are important paracrine and/or autocrine regulators of spermatogenesis in bovine.

  7. MT1-MMP (show MMP14 Antibodies) has a role in signaling events mediating EGFR transactivation

  8. possible cooperative role of the EGF (show EGF Antibodies) and HGF (show HGF Antibodies) pathways and indicate that cross-talk between their respective receptors may modulate mammary gland development in the cow

  9. EGFR is stimulated during capacitation via PKA activation. More activation induces the acrosome reaction, which is induced by GPCR via EGFR transactivation by a signaling pathway involving PKA, SRC & metalloproteinase & effectors PI3K, PLC & PKC.

EGFR Antigen Profile

Antigen Summary

The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer. Multiple alternatively spliced transcript variants that encode different protein isoforms have been found for this gene.

Alternative names and synonyms associated with EGFR

  • epidermal growth factor receptor (EGFR) antibody
  • Epidermal growth factor receptor (Egfr) antibody
  • epidermal growth factor receptor a (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) (egfra) antibody
  • epidermal growth factor receptor (egfr1) antibody
  • epidermal growth factor receptor (AaeL_AAEL004319) antibody
  • epidermal growth factor receptor (Egfr) antibody
  • epidermal growth factor receptor (LOC100008806) antibody
  • 9030024J15Rik antibody
  • AI552599 antibody
  • C-erb antibody
  • c-erbB antibody
  • CG10079 antibody
  • D-Egf antibody
  • d-egf-r antibody
  • D-EGFR antibody
  • dEgfr antibody
  • dEGFR1 antibody
  • der antibody
  • DER/EGFR antibody
  • DER/faint little ball antibody
  • DER/top antibody
  • DER/torpedo antibody
  • DER1 antibody
  • DER flb antibody
  • Dmel\\CG10079 antibody
  • DmHD-33 antibody
  • EFG-R antibody
  • Egf antibody
  • Egf-r antibody
  • egfr antibody
  • egfr1 antibody
  • EGFR12 antibody
  • EGFR15 antibody
  • EK2-6 antibody
  • El antibody
  • Elp antibody
  • Elp-1 antibody
  • Elp-B1 antibody
  • Elp-B1RB1 antibody
  • Erbb antibody
  • ErbB-1 antibody
  • ERBB1 antibody
  • Erbb2 antibody
  • Errb1 antibody
  • Errp antibody
  • flb antibody
  • HD-33 antibody
  • HER1 antibody
  • l(2)05351 antibody
  • l(2)09261 antibody
  • l(2)57DEFa antibody
  • l(2)57Ea antibody
  • l(2)57EFa antibody
  • mENA antibody
  • mor1 antibody
  • PIG61 antibody
  • top antibody
  • top/DER antibody
  • top/flb antibody
  • Torpedo/DER antibody
  • torpedo/egfr antibody
  • wa-2 antibody
  • wa2 antibody
  • Wa5 antibody

Protein level used designations for EGFR

CG10079-PA , CG10079-PB , DER-Ellipse , EGF-receptor , EGFR , Egf receptor , Egfr-PA , Egfr-PB , drosophila epidermal growth factor receptor homologue , ellipse , ellipse torpedo , epidermal growth factor receptor , faint little ball , morphological defects 1 , torpedo , torpedo/DER , erbb1a , avian erythroblastic leukemia viral (v-erb-b) oncogene homolog , cell growth inhibiting protein 40 , cell proliferation-inducing protein 61 , proto-oncogene c-ErbB-1 , receptor tyrosine-protein kinase erbB-1 , EGFR-related peptide , Epidermal growth factor receptor formerly avian erythroblastic leukemia viral (v-erbB) oncogene homolog (Erbb1) , avian erythroblastic leukemia viral (v-erbB) oncogene homolog , epidermal growth factor receptor, formerly avian erythroblastic leukemia viral (v-erbB) oncogene homolog (Erbb1) , waved 2 , CER , epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) , egf receptor , receptor tyrosine kinase ErbB1

100067755 Equus caballus
37455 Drosophila melanogaster
378478 Danio rerio
778955 Ciona intestinalis
5564544 Aedes aegypti
1956 Homo sapiens
24329 Rattus norvegicus
13649 Mus musculus
396494 Gallus gallus
397070 Sus scrofa
404306 Canis lupus familiaris
407217 Bos taurus
100008806 Oryctolagus cuniculus
100725363 Cavia porcellus
780479 Ovis aries
613027 Macaca mulatta
Selected quality suppliers for anti-EGFR (EGFR) Antibodies
Did you look for something else?